UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2009, Vol.374 (9700), p.1503-1511

2009

Volltextzugriff (PDF)

Pregnancy, delivery, and birth outcome in women with multiple sclerosis

Neurology, 2005-12, Vol.65 (12), p.1961-1963

2005

Volltextzugriff (PDF)

Disease-modifying treatments for multiple sclerosis - a review of approved medications

European journal of neurology, 2016-01, Vol.23 (S1), p.18-27

2016

Volltextzugriff (PDF)

Pain and sensory complaints in multiple sclerosis

European journal of neurology, 2004-07, Vol.11 (7), p.479-482

2004

Volltextzugriff (PDF)

Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts

CNS drugs, 2017-01, Vol.31 (1), p.33-50

2017

Volltextzugriff (PDF)

Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis

European journal of neurology, 2015-02, Vol.22 (2), p.328-333

2015

Volltextzugriff (PDF)

The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis

PloS one, 2019, Vol.14 (12), p.e0227120-e0227120

2019

Volltextzugriff (PDF)

Health-related quality of life among young adults with ischemic stroke on long-term follow-up

Stroke (1970), 2006-05, Vol.37 (5), p.1232-1236

2006

Volltextzugriff (PDF)

Guidelines on use of anti-IFN-β antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-β antibodies in multiple sclerosis

European journal of neurology, 2005-11, Vol.12 (11), p.817-827

2005

Volltextzugriff (PDF)

Caregiver burden in multiple sclerosis: the impact of neuropsychiatric symptoms

Journal of neurology, neurosurgery and psychiatry, 2007-10, Vol.78 (10), p.1097-1102

2007

Volltextzugriff (PDF)

Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome

Multiple sclerosis, 2013-07, Vol.19 (8), p.1074-1083

2013

Volltextzugriff (PDF)

IL-6: an early marker for outcome in acute ischemic stroke

Acta neurologica Scandinavica, 2005-06, Vol.111 (6), p.360-365

2005

Volltextzugriff (PDF)

Relationship of cognitive impairment to psychiatric symptoms in multiple sclerosis

Multiple sclerosis, 2008-09, Vol.14 (8), p.1084-1090

2008

Volltextzugriff (PDF)

The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis

Multiple sclerosis and related disorders, 2024-11, Vol.91, p.105900, Article 105900

2024

Volltextzugriff (PDF)

Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway

Multiple sclerosis, 2008-11, Vol.14 (9), p.1191-1198

2008

Volltextzugriff (PDF)

Pregnancy and Infant Outcomes with Interferon Beta: Data from the European Interferon Beta Pregnancy Registry and MS Preg study conducted in Finland and Sweden (S49.005)

Neurology, 2019, Vol.92 (15_supplement)

2019

Volltextzugriff (PDF)

Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab

Multiple sclerosis, 2011-09, Vol.17 (9), p.1074-1078

2011

Volltextzugriff (PDF)

Prevalence of infant outcomes at birth after exposure to interferon beta prior to or during pregnancy: a register-based cohort study in Finland and Sweden among women with MS

MULTIPLE SCLEROSIS JOURNAL, 2019, Vol.25 (Suppl. 2), p.619

2019

Volltextzugriff (PDF)

Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort

European journal of human genetics : EJHG, 2015-05, Vol.23 (5), p.688-692

2015

Volltextzugriff (PDF)

A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway

Neurology, 2006-01, Vol.66 (2), p.182-186

2006

Volltextzugriff (PDF)

Reply to comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'

Acta neurologica Scandinavica, 2015-11, Vol.132 (5), p.368-369

2015

Volltextzugriff (PDF)

Quality of life in multiple sclerosis: measuring the disease effects more broadly

Neurology, 1999-09, Vol.53 (5), p.1098-1098

1999

Volltextzugriff (PDF)

A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis

European journal of human genetics : EJHG, 2010-04, Vol.18 (4), p.502-504

2010

Volltextzugriff (PDF)

Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS

Acta neurologica Scandinavica, 2012-12, Vol.126 (s195), p.24-30

2012

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(85)
Tagungsberichte
(12)

Sprache

Englisch
(97)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

Pregnancy, delivery, and birth outcome in women with multiple sclerosis

Disease-modifying treatments for multiple sclerosis - a review of approved medications

Pain and sensory complaints in multiple sclerosis

Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts

Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis

The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis

Health-related quality of life among young adults with ischemic stroke on long-term follow-up

Guidelines on use of anti-IFN-β antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-β antibodies in multiple sclerosis

Caregiver burden in multiple sclerosis: the impact of neuropsychiatric symptoms

Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome

IL-6: an early marker for outcome in acute ischemic stroke

Relationship of cognitive impairment to psychiatric symptoms in multiple sclerosis

The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis

Multiple sclerosis registries in Europe – results of a systematic survey

Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway

Pregnancy and Infant Outcomes with Interferon Beta: Data from the European Interferon Beta Pregnancy Registry and MS Preg study conducted in Finland and Sweden (S49.005)

Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab

Prevalence of infant outcomes at birth after exposure to interferon beta prior to or during pregnancy: a register-based cohort study in Finland and Sweden among women with MS

Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort

A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway

Reply to comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'

Quality of life in multiple sclerosis: measuring the disease effects more broadly

A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis

Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS

Suchergebnisse filtern